Contact this trialFirst, we need to learn more about you.
Immunotherapy
AN0025 + Pembrolizumab for Advanced Cancer
Recruiting1 awardPhase 1
Saint Louis, Missouri
This trial is testing a new combination drug to treat advanced tumors. The goal is to find the best dose of the new drug while monitoring side effects. The trial will last for two years.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.